ArticleBritish journal of cancer2023

Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.

Dong-Yang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.